Cure Parkinson’s Trust, Van Andel Institute Give $4.5M to Support Trials into New Treatments

Related Articles:

• Cure Parkinson’s Trust, Van Andel Institute Give $4.5M to Support Trials into New Treatments February 14, 2020 Cure Parkinson’s Trust (CPT) and the Van Andel Institute (VAI) will contribute $4.5 million in total to support a global program that seeks to develop disease-modifying Parkinson’s therapies. The three-year funding agreement backs the international Linked Clinical Trials (LCT) initiative, established by the two organizations in 2012 to identify treatments that might slow, stop, and reverse Parkinson’s disease (PD) largely by…
• The International Linked Clinical Trials Programme for Parkinson's February 13, 2020 The Cure Parkinson’s Trust (CPT) and the Van Andel Institute (VAI) are delighted to announce a new three-year co-funding agreement that pledges USD $4.5 million to Parkinson’s research, strengthening an already long-standing partnership. This funding will support the International Linked Clinical Trials (iLCT) initiative, a thriving global programme that aims to develop new, potentially disease-modifying Parkinson’s therapies, many of which…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Promising Respiratory Drug Focus of New Trial for Parkinson's August 8, 2017 The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or…
• Linked Clinical Trial partnership October 1, 2018 The international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop and reverse Parkinson’s disease by repurposing drugs that have been approved to treat other conditions. The LCT scientific committee prioritises new treatments once a year to identify the most promising drugs to fast-track into clinical trials, with the hope of not only proving efficacy but also…
• Linked Clinical Trial partnership October 1, 2018 The international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop and reverse Parkinson’s disease by repurposing drugs that have been approved to treat other conditions. The LCT scientific committee prioritises new treatments once a year to identify the most promising drugs to fast-track into clinical trials, with the hope of not only proving efficacy but also…
• Linked Clinical Trials Initiative Boosts Number of Parkinson’s Clinical Studies October 9, 2018 The Linked Clinical Trials (LCT) Initiative, a repurposing program that aims to identify existing medicines which can slow the progression of Parkinson’s disease, has resulted in a growing number of clinical trials. The partnership’s history, purpose and activities are the focus of an article, “The Linked Clinical Trials Initiative (LCT) for Parkinson’s disease,” that recently appeared in the European Journal of Neuroscience.…
• The Cure Collective February 14, 2019 About the Cure Collective The Cure Collective is your opportunity to join with like-minded individuals who are all committed to help drive forward the quest to find a cure for Parkinson’s. By committing your support with a minimum annual donation of £5,000 or more (for a period of at least five years or longer) you will enable us to plan…
• The Cure Collective February 14, 2019 About the Cure Collective The Cure Collective is your opportunity to join with like-minded individuals who are all committed to help drive forward the quest to find a cure for Parkinson’s. By committing your support with a minimum annual donation of £5,000 or more (for a period of at least five years or longer) you will enable us to plan…
• Trials - Repurposed drugs September 16, 2019 Donate The journey to discovering new treatments for Parkinson's (PD) is lengthy and expensive. The Cure Parkinson's Trust (CPT) is determined to fast-track potential new treatments to slow, stop, or reverse PD. Our international Linked Clinical Trials initiative (LCT) 'repurposes' already approved and available drugs and therapies for other conditions, with the potential for treatment of Parkinson's, reducing the time to reach patients…
• Trials - Repurposed drugs February 25, 2019 Donate The journey to discovering new treatments for Parkinson's (PD) is lengthy and expensive. The Cure Parkinson's Trust (CPT) is determined to fast-track potential new treatments to slow, stop, or reverse PD. Our international Linked Clinical Trials initiative (LCT) 'repurposes' already approved and available drugs and therapies for other conditions, with the potential for treatment of Parkinson's, reducing the time to reach patients…
• World Parkinson's Day Announcement - Our Global Linked Clinical Trials Programme April 13, 2017 World Parkinson's Day Announcement. Our Global Linked Clinical Trials Programme: 10 trials in five years, 10 ways to potentially slow, stop and ultimately reverse Parkinson’s rapidly! On World Parkinson's Day (11th April), The Cure Parkinson’s Trust (CPT) is delighted to announce its collaboration with the Garvan Institute, Shake It Up Australia and Parkinson’s Australia to explore running Parkinson's clinical trials…
• World Parkinson's Day Announcement - Our Global Linked Clinical Trials Programme April 13, 2017 World Parkinson's Day Announcement. Our Global Linked Clinical Trials Programme: 10 trials in five years, 10 ways to potentially slow, stop and ultimately reverse Parkinson’s rapidly! On World Parkinson's Day (11th April), The Cure Parkinson’s Trust (CPT) is delighted to announce its collaboration with the Garvan Institute, Shake It Up Australia and Parkinson’s Australia to explore running Parkinson's clinical trials…
• Drug Repurposing in Parkinson's May 10, 2019 “As we’ve learned more about Parkinson’s, we’ve found that it shares some of the same underlying molecular pathways and mechanisms as other diseases. For example, there is overlap with diabetes as well as some inflammatory disorders. Investigating drugs that were originally designed to treat these other diseases and that act on these shared pathways provides a particularly promising avenue for…